AVANOS MED INC's ticker is AVNS and the CUSIP is 05350V106. A total of 251 filers reported holding AVANOS MED INC in Q3 2023. The put-call ratio across all filers is 1.32 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,836 | -20.9% | 437 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $11,170 | -14.1% | 437 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $12,996 | +9.9% | 437 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $11,825 | +18.2% | 437 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $10,000 | -16.7% | 437 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $12,000 | -20.0% | 437 | -2.0% | 0.00% | -50.0% |
| Q1 2022 | $15,000 | -11.8% | 446 | -10.1% | 0.00% | 0.0% |
| Q4 2021 | $17,000 | +13.3% | 496 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $15,000 | -61.5% | 496 | -48.9% | 0.00% | 0.0% |
| Q2 2021 | $39,000 | +85.7% | 970 | +100.0% | 0.00% | -33.3% |
| Q1 2021 | $21,000 | +50.0% | 485 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $14,000 | +7.7% | 485 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $13,000 | -18.8% | 485 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $16,000 | -11.1% | 485 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $18,000 | -14.3% | 485 | 0.0% | 0.00% | -25.0% |
| Q2 2019 | $21,000 | – | 485 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradice Investment Management LLC | 3,087,229 | $96,322,000 | 4.36% |
| RGM Capital, LLC | 2,521,930 | $78,684,000 | 3.86% |
| Tributary Capital Management, LLC | 322,946 | $10,076,000 | 0.78% |
| Alpha Paradigm Partners, LLC | 52,844 | $1,649,000,000 | 0.66% |
| HEARTLAND ADVISORS INC | 307,416 | $9,591,000 | 0.58% |
| Factorial Partners, LLC | 23,400 | $730,000 | 0.50% |
| Champlain Investment Partners, LLC | 2,082,903 | $64,987,000 | 0.31% |
| WESTWOOD HOLDINGS GROUP INC | 741,503 | $23,135,000 | 0.25% |
| Campbell & CO Investment Adviser LLC | 22,100 | $690,000 | 0.22% |
| AIGEN INVESTMENT MANAGEMENT, LP | 26,488 | $826,000 | 0.16% |